Caption Management, LLC Cardiol Therapeutics Inc. Transaction History
Caption Management, LLC
- $5.74 Billion
- Q3 2024
A detailed history of Caption Management, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Caption Management, LLC holds 99,900 shares of CRDL stock, worth $139,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,900Holding current value
$139,860% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRDL
# of Institutions
44Shares Held
4.92MCall Options Held
5.2KPut Options Held
9.5K-
Tejara Capital LTD London, X01.77MShares$2.48 Million1.67% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.17MShares$1.64 Million0.46% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$1.11 Million0.31% of portfolio
-
Lion Street Advisors, LLC308KShares$430,7320.13% of portfolio
-
Mgo One Seven LLC Beachwood, OH100KShares$140,0000.01% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $86.7M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...